Sunshine Biopharma Inc.
SBFM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001402328
No open-market purchases or sales by Sunshine Biopharma Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $32.6K in total; no superinvestor holds it.
Other share classesSBFMW
Q1 2022 vs. Q4 2021
How the institutions holding Sunshine Biopharma Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 1 | 13 | +12 |
| Shares | 292.7K | 1.47M | +1.18M (+402.1%) |
| Value | $17.0K | $3.55M | +$3.53M (+20,783.5%) |
New holders (12)
Institutions that held Sunshine Biopharma Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 635,002 | $1.56M | 0.04% |
| Empery Asset Management, LP | 450,450 | $1.10M | 5.19% |
| Hudson Bay Capital Management LP | 315,000 | $720.0K | 0.01% |
| Geode Capital Management, LLC | 20,179 | $49.0K | 0.00% |
| Virtu Financial LLC | 13,963 | $34.0K | 0.00% |
| Two Sigma Securities, LLC | 13,047 | $32.0K | 0.00% |
| Jane Street Group, LLC | 12,640 | $31.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 4,085 | $10.0K | 0.00% |
| UBS Group AG | 2,434 | $6.00K | 0.00% |
| National Bank of Canada | 1,042 | $3.00K | 0.00% |
| Signaturefd, LLC | 300 | $1.00K | 0.00% |
| Federation des caisses Desjardins du Quebec | 79 | $194 | 0.00% |
Sold out (0)
Institutions that held Sunshine Biopharma Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
None.